Skip to main content
TipRanks
Go Ultimate75% OFF

Glooko Highlights Cloud-Based Insulin Dosing Platform

Glooko Highlights Cloud-Based Insulin Dosing Platform

According to a recent LinkedIn post from Glooko, the company is highlighting EndoTool IV Cloud, a cloud-based version of its patient-specific insulin dosing algorithm. The post suggests the platform is designed to help care teams manage blood glucose levels while providing health-system IT teams with a simpler, more scalable deployment model.

The offering could support Glooko’s position in digital health by addressing demand for clinically focused tools that integrate into complex hospital environments. A cloud-based model may also reduce implementation and maintenance burdens, potentially improving scalability across health systems, although the post does not provide customer, revenue, clinical-outcome, or adoption data.

For investors, the update points to a strategy centered on extending Glooko’s technology into hospital-based glycemic management. Its financial impact will likely depend on health-system uptake, evidence of improved efficiency or patient outcomes, and the company’s ability to compete with other clinical decision-support and diabetes-management platforms.

Disclaimer & DisclosureReport an Issue

Related Articles